RAPT Therapeutics (RAPT) Research & Development: 2020-2023
Historic Research & Development for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $26.8 million.
- Therapeutics' Research & Development rose 37.58% to $26.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $101.0 million, marking a year-over-year increase of 50.56%. This contributed to the annual value of $101.0 million for FY2023, which is 50.56% up from last year.
- According to the latest figures from Q4 2023, Therapeutics' Research & Development is $26.8 million, which was down 0.95% from $27.0 million recorded in Q3 2023.
- In the past 5 years, Therapeutics' Research & Development registered a high of $27.0 million during Q3 2023, and its lowest value of $10.7 million during Q1 2020.
- In the last 3 years, Therapeutics' Research & Development had a median value of $16.6 million in 2022 and averaged $18.8 million.
- Data for Therapeutics' Research & Development shows a peak YoY spiked of 62.79% (in 2023) over the last 5 years.
- Over the past 4 years, Therapeutics' Research & Development (Quarterly) stood at $10.9 million in 2020, then spiked by 31.14% to $14.3 million in 2021, then spiked by 36.05% to $19.5 million in 2022, then surged by 37.58% to $26.8 million in 2023.
- Its Research & Development was $26.8 million in Q4 2023, compared to $27.0 million in Q3 2023 and $21.6 million in Q2 2023.